论文部分内容阅读
目的:测算陕西省城市公立医院取消药品加成政策性亏损,为相关部门制定卫生政策提供参考。方法:采用简单移动平均法,测算2015—2020年陕西省城市公立医院因药品零差率销售形成的政策性亏损。结果:2015—2020年陕西省城市公立医院政策性亏损分别约为11.29亿元、13.76亿元、16.77亿元、20.45亿元、24.94亿元和30.42亿元。结论:取消药品加成后,为确保陕西省城市公立医院平稳有序运行,建议科学测算药品零差率改革成本及其潜在风险;坚持政府主导,明确政府投入责任;“三医”联动,探索城市公立医院科学、长效补偿机制。
OBJECTIVE: To estimate the policy-related losses of drug additions in urban public hospitals in Shaanxi Province and provide references for relevant departments to formulate health policies. Methods: The simple moving average method was used to measure the policy-related losses caused by sales of drug zero-difference rate in urban public hospitals in Shaanxi Province from 2015 to 2020. Results: The policy losses of urban public hospitals in Shaanxi Province from 2015 to 2020 were about 1.129 billion yuan, 1.376 billion yuan, 1.677 billion yuan, 2.045 billion yuan, 2.494 billion yuan and 3.042 billion yuan respectively. Conclusion: After canceling the drug add-on, to ensure the stable and orderly operation of urban public hospitals in Shaanxi Province, it is suggested to scientifically calculate the cost and potential risks of zero-turnover rate of drug products; to insist on government-led and clear responsibility of government; , Explore the city public hospital science, long-term compensation mechanism.